These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9128 related articles for article (PubMed ID: 1337602)

  • 21. [111In]-DTPA-labeled analogues of alpha-melanocyte-stimulating hormone for melanoma targeting: receptor binding in vitro and in vivo.
    Bagutti C; Stolz B; Albert R; Bruns C; Pless J; Eberle AN
    Int J Cancer; 1994 Sep; 58(5):749-55. PubMed ID: 8077062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced binding and inertness to dehalogenation of alpha-melanotropic peptides labeled using N-succinimidyl 3-iodobenzoate.
    Garg PK; Alston KL; Welsh PC; Zalutsky MR
    Bioconjug Chem; 1996; 7(2):233-9. PubMed ID: 8983345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative biological activities of alpha-MSH antagonists in vertebrate pigment cells.
    Castrucci AM; Almeida AL; al-Obeidi FA; Hadley ME; Hruby VJ; Staples DJ; Sawyer TK
    Gen Comp Endocrinol; 1997 Mar; 105(3):410-6. PubMed ID: 9073503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioral effects of [4-norleucine, 7-D-phenylalanine]-alpha-melanocyte-stimulating hormone.
    Kobobun K; O'Donohue TL; Handelmann GE; Sawyer TK; Hruby VJ; Hadley ME
    Peptides; 1983; 4(5):721-4. PubMed ID: 6657517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Truncation studies of alpha-melanotropin peptides identify tripeptide analogues exhibiting prolonged agonist bioactivity.
    Haskell-Luevano C; Sawyer TK; Hendrata S; North C; Panahinia L; Stum M; Staples DJ; Castrucci AM; Hadley MF; Hruby VJ
    Peptides; 1996; 17(6):995-1002. PubMed ID: 8899819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells.
    Murata J; Ayukawa K; Ogasawara M; Fujii H; Saiki I
    Invasion Metastasis; 1997; 17(2):82-93. PubMed ID: 9561027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclic lactam analogues of Ac-[Nle4]alpha-MSH4-11-NH2.
    Sugg EE; Castrucci AM; Hadley ME; van Binst G; Hruby VJ
    Biochemistry; 1988 Oct; 27(21):8181-8. PubMed ID: 2852955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical application of a melanotropic peptide induces systemic follicular melanogenesis.
    Hadley ME; Wood SH; Lemus-Wilson AM; Dawson BV; Levine N; Dorr RT; Hruby VJ
    Life Sci; 1987 May; 40(19):1889-95. PubMed ID: 3573985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis.
    Froidevaux S; Calame-Christe M; Tanner H; Sumanovski L; Eberle AN
    J Nucl Med; 2002 Dec; 43(12):1699-706. PubMed ID: 12468522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.
    Froidevaux S; Calame-Christe M; Schuhmacher J; Tanner H; Saffrich R; Henze M; Eberle AN
    J Nucl Med; 2004 Jan; 45(1):116-23. PubMed ID: 14734683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of alpha-melanocyte-stimulating hormone and its analog on the growth of human melanoma cell lines with different phenotypes].
    Morozova LF; D'iakov VL; Sukhanov VA
    Tsitologiia; 1993; 35(1):101-4. PubMed ID: 8386407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery and structure-activity relationships of novel alpha-melanocyte-stimulating hormone inhibitors.
    Sawyer TK; Staples DJ; Castrucci AM; Hadley ME
    Pept Res; 1989; 2(1):140-6. PubMed ID: 2562482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of S91 melanoma tyrosinase activity by superpotent alpha-melanotropins.
    Marwan MM; Abdel Malek ZA; Kreutzfeld KL; Hadley ME; Wilkes BC; Hruby VJ; Castrucci AM
    Mol Cell Endocrinol; 1985 Jul; 41(2-3):171-7. PubMed ID: 3926559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorine-18-labeled [Nle4,D-Phe7]-alpha-MSH, an alpha-melanocyte stimulating hormone analogue.
    Vaidyanathan G; Zalutsky MR
    Nucl Med Biol; 1997 Feb; 24(2):171-8. PubMed ID: 9089709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melanoma targeting with alpha-melanocyte stimulating hormone analogs labeled with fac-[99mTc(CO)3]+: effect of cyclization on tumor-seeking properties.
    Raposinho PD; Xavier C; Correia JD; Falcão S; Gomes P; Santos I
    J Biol Inorg Chem; 2008 Mar; 13(3):449-59. PubMed ID: 18183429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of an alpha-melanocyte-stimulating hormone analogue to improve alpha-melanocyte-stimulating hormone receptor binding assay in human melanoma.
    Libert A; Ghanem G; Arnould R; Lejeune FJ
    Pigment Cell Res; 1989; 2(6):510-8. PubMed ID: 2557606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological activities of melanotropic peptide fatty acid conjugates.
    Hadley ME; al-Obeidi F; Hruby VJ; Weinrach JC; Freedberg D; Jiang JW; Stover RS
    Pigment Cell Res; 1991 Oct; 4(4):180-5. PubMed ID: 1667821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of an alpha-melanocyte-stimulating hormone-diphtheria toxin fusion protein with melanotropin receptors in human melanoma metastases.
    Tatro JB; Wen Z; Entwistle ML; Atkins MB; Smith TJ; Reichlin S; Murphy JR
    Cancer Res; 1992 May; 52(9):2545-8. PubMed ID: 1314697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor alpha increases and alpha-melanocyte-stimulating hormone reduces uveal melanoma invasion through fibronectin.
    Cantón I; Eves PC; Szabo M; Vidal-Vanaclocha F; Sisley K; Rennie IG; Haycock JW; MacNeil S
    J Invest Dermatol; 2003 Sep; 121(3):557-63. PubMed ID: 12925215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
    Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
    Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 457.